中华实验外科杂志
中華實驗外科雜誌
중화실험외과잡지
CHINESE JOURNAL OF EXPERIMENTAL SURGERY
2015年
8期
1795-1797
,共3页
曹静%吕志排%曾宪旭%雷冬梅%张威%郝志伟
曹靜%呂誌排%曾憲旭%雷鼕梅%張威%郝誌偉
조정%려지배%증헌욱%뢰동매%장위%학지위
肺神经内分泌癌%临床病理特征%预后
肺神經內分泌癌%臨床病理特徵%預後
폐신경내분비암%림상병리특정%예후
Pulmonary neuroendocrine carcinoma%Clinicopathological features%Prognosis
目的 探讨肺神经内分泌癌的临床病理特征及其分级和预后的关系.方法 复习166例肺神经内分泌癌的临床病理资料,分析其神经内分泌免疫标记嗜铬素A(CgA)、突触素(Syn)、CD56表达的阳性率.并参照2010年版世界卫生组织(WHO)消化系统胃肠胰神经内分泌肿瘤分级标准对肺神经内分泌癌进行分级,分别比较肿瘤组织分型及新分级与预后的相互关系.结果 典型类癌(TC)和不典型类癌(AC)患者标本CgA、Syn、CD56的表达相同(P>0.05),阳性率分别为90.7%、91.3%、87.5%及63.1%、83.3%、89.4%.而在小细胞癌(SCLC)和大细胞神经内分泌癌(LCNEC)中表达不同(P<0.05),阳性率分别为38.1%、82.4%、90.5%及33.3%、76.9%、66.7%.肺神经内分泌癌的组织分型及新分级均与预后相关(P<0.05).TC预后最好,其余依次为AC、LCNEC、SCLC.NET G1预后最好,其余依次为NET G2、NEC G3.结论 肺神经内分泌癌依据Ki-67增殖指数进行分级,能较准确的反映预后.
目的 探討肺神經內分泌癌的臨床病理特徵及其分級和預後的關繫.方法 複習166例肺神經內分泌癌的臨床病理資料,分析其神經內分泌免疫標記嗜鉻素A(CgA)、突觸素(Syn)、CD56錶達的暘性率.併參照2010年版世界衛生組織(WHO)消化繫統胃腸胰神經內分泌腫瘤分級標準對肺神經內分泌癌進行分級,分彆比較腫瘤組織分型及新分級與預後的相互關繫.結果 典型類癌(TC)和不典型類癌(AC)患者標本CgA、Syn、CD56的錶達相同(P>0.05),暘性率分彆為90.7%、91.3%、87.5%及63.1%、83.3%、89.4%.而在小細胞癌(SCLC)和大細胞神經內分泌癌(LCNEC)中錶達不同(P<0.05),暘性率分彆為38.1%、82.4%、90.5%及33.3%、76.9%、66.7%.肺神經內分泌癌的組織分型及新分級均與預後相關(P<0.05).TC預後最好,其餘依次為AC、LCNEC、SCLC.NET G1預後最好,其餘依次為NET G2、NEC G3.結論 肺神經內分泌癌依據Ki-67增殖指數進行分級,能較準確的反映預後.
목적 탐토폐신경내분비암적림상병리특정급기분급화예후적관계.방법 복습166례폐신경내분비암적림상병리자료,분석기신경내분비면역표기기락소A(CgA)、돌촉소(Syn)、CD56표체적양성솔.병삼조2010년판세계위생조직(WHO)소화계통위장이신경내분비종류분급표준대폐신경내분비암진행분급,분별비교종류조직분형급신분급여예후적상호관계.결과 전형유암(TC)화불전형유암(AC)환자표본CgA、Syn、CD56적표체상동(P>0.05),양성솔분별위90.7%、91.3%、87.5%급63.1%、83.3%、89.4%.이재소세포암(SCLC)화대세포신경내분비암(LCNEC)중표체불동(P<0.05),양성솔분별위38.1%、82.4%、90.5%급33.3%、76.9%、66.7%.폐신경내분비암적조직분형급신분급균여예후상관(P<0.05).TC예후최호,기여의차위AC、LCNEC、SCLC.NET G1예후최호,기여의차위NET G2、NEC G3.결론 폐신경내분비암의거Ki-67증식지수진행분급,능교준학적반영예후.
Objective To investigate the clinicopathological features of pulmonary neuroendocrine carcinoma and correlation between its pathologic stage and prognosis.Methods The expression of neuroendocrine immunohistochemical markers such as chromogranin A (CgA),synaptic element (Syn) and CD56 were analyzed in 166 patients.According to the 2010 World Health Organization (WHO) classification and staging system of gastroenteropancreatic NENs,pulmonary neuroendocrine carcinoma were classified into different pathologic grading.The relationship between histological classification,pathologic grading and prognosis were compared with respectively.Results The expression of CgA,Syn and CD56 in typical carcinoid (TC) specimen were same with in atypical carcinoid (AC,P > 0.05),the positive rates were 90.7%,91.3%,87.5% and 63.1%,83.3%,89.4% respectively.while were different in small cell lung cancer (SCLC) and large cell neuroendocrine carcinoma (LCNEC) specimen (P < 0.05),the positive rateswere 38.1%,82.4%,90.5% and 33.3%,76.9%,66.7% respectively.Histological classification and pathologic grading had relation with prognosis (P < 0.05).The prognosis of TC is the best,followed by AC,LCNEC,SCLC.Similarly,NET G1 the best prognosis,followed by NET G2,NEC G3.Conclusion On the basis of Ki-67 proliferation index for pathologic stage was useful for long-term prognostic value.